-
1
-
-
34447289622
-
Pathogenic mutations in Parkinson disease
-
Tan EK, Skipper LM Pathogenic mutations in Parkinson disease. Hum Mutat 2007, 28:641-653.
-
(2007)
Hum Mutat
, vol.28
, pp. 641-653
-
-
Tan, E.K.1
Skipper, L.M.2
-
2
-
-
8844233579
-
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology
-
Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004, 44:601-607.
-
(2004)
Neuron
, vol.44
, pp. 601-607
-
-
Zimprich, A.1
Biskup, S.2
Leitner, P.3
-
3
-
-
8844266996
-
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
-
Paisan-Ruiz C, Jain S, Evans EW, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004, 44:595-600.
-
(2004)
Neuron
, vol.44
, pp. 595-600
-
-
Paisan-Ruiz, C.1
Jain, S.2
Evans, E.W.3
-
4
-
-
50049104725
-
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
-
Healy DG, Falchi M, O'Sullivan SS, et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 2008, 7:583-590.
-
(2008)
Lancet Neurol
, vol.7
, pp. 583-590
-
-
Healy, D.G.1
Falchi, M.2
O'Sullivan, S.S.3
-
5
-
-
80052967403
-
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study
-
published online Aug 31
-
Ross OA, Soto-Ortolaza AI, Heckman MG, et al. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Lancet Neurol 2011, published online Aug 31. 10.1016/S1474-4422(11)70175-2.
-
(2011)
Lancet Neurol
-
-
Ross, O.A.1
Soto-Ortolaza, A.I.2
Heckman, M.G.3
-
6
-
-
77951876814
-
Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study
-
Tan EK, Peng R, Teo YY, et al. Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study. Hum Mutat 2010, 31:561-568.
-
(2010)
Hum Mutat
, vol.31
, pp. 561-568
-
-
Tan, E.K.1
Peng, R.2
Teo, Y.Y.3
-
7
-
-
70350450693
-
LRRK2 in Parkinson's disease: function in cells and neurodegeneration
-
Webber PJ, West AB LRRK2 in Parkinson's disease: function in cells and neurodegeneration. FEBS J 2009, 276:6436-6444.
-
(2009)
FEBS J
, vol.276
, pp. 6436-6444
-
-
Webber, P.J.1
West, A.B.2
-
8
-
-
70349103837
-
Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila
-
Ng CH, Mok SZ, Koh C, et al. Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila. J Neurosci 2009, 29:11257-11262.
-
(2009)
J Neurosci
, vol.29
, pp. 11257-11262
-
-
Ng, C.H.1
Mok, S.Z.2
Koh, C.3
-
9
-
-
77952409692
-
Deletion of the WD40 domain of LRRK2 in Zebrafish causes Parkinsonism-like loss of neurons and locomotive defect
-
Sheng D, Qu D, Kwok KH, et al. Deletion of the WD40 domain of LRRK2 in Zebrafish causes Parkinsonism-like loss of neurons and locomotive defect. PLoS Genet 2010, 6:e1000914.
-
(2010)
PLoS Genet
, vol.6
-
-
Sheng, D.1
Qu, D.2
Kwok, K.H.3
-
10
-
-
77956441086
-
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
-
Lee BD, Shin JH, Van Kampen J, et al. Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease. Nat Med 2010, 16:998-1000.
-
(2010)
Nat Med
, vol.16
, pp. 998-1000
-
-
Lee, B.D.1
Shin, J.H.2
Van Kampen, J.3
|